Overview


According to FutureWise analysis the market for antibiotic active pharmaceutical ingredient in 2023 is US$ 8.65 billion, and is expected to reach US$ 11.41 billion by 2031 at a CAGR of 3.5%.

Active Pharmaceutical Ingredients are the main biologically active components in pharmaceutical drugs that produce the therapeutic effect. These substances treat or prevent a particular medical condition. APIs are the core of any medication and are carefully selected and developed based on their pharmacological properties. Antibiotics are compounds that destroy or inhibit the growth of other pathogenic microorganisms and are used to treat external or internal infections. While some antibiotics are produced by microorganisms, most are now manufactured synthetically. Active Pharmaceutical Ingredients (APIs) exist in various forms, such as small molecules, proteins, peptides, nucleic acids, etc. They undergo rigorous testing and clinical trials to ensure their safety and effectiveness before being approved for use in pharmaceutical products.

APIs can be natural or synthetic chemical-based active compounds that are usually found in therapeutic and veterinary drugs. There are chemical-based active compounds produced using unsafe chemical routes. Therefore, their wide production, usage, and disposal are becoming hazardous to humans, water bodies (including drinking water), and other bio-based lives owing to their uncontrolled contact with the environment. Furthermore, the presence of these compounds has been detected in trace levels from nanograms to micrograms in the last ten years from groundwater, drinking water, and wastewater. Although the formation of these chemical compounds is not from a single reaction source, they are developed from many chemical components that are usually initiated from a single intermediate. Furthermore, several intermediates are formed to convert raw material into an API. These several reactions usually pass through the long channels of purification during their developmental engineering, which involves the usage of huge reactors.

FutureWise Market Research has published a report that provides an insightful analysis antibiotic active pharmaceuticals ingredients market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, antibiotic active pharmaceuticals ingredients market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Sandoz International GmbH
  • Centrient Pharmaceuticals
  • CordenPharma International
  • ACS DOBFAR SPA
  • Nanjing Dorra Pharmaceutical Technology Co. Ltd.
  • DAEWOONG PHARMACEUTICAL CO. LTD.
  • Parabolic Drugs Ltd.
  • Penam Laboratories Ltd.
  • ASIATIC DRUGS and PHARMACEUTICALS PVT. LTD.
  • Fresenius Kabi
  • The United Laboratories International Holdings Limited
  • Aurobindo Pharma Limited
  • Unimark Remedies Ltd.
  • Savior Lifetec
  • Shenzhen Haibin Pharmaceutical Co., Ltd.
  • Sterile India Pvt. Ltd.
  • Zhejiang Jiuzhou Pharmaceutical Co. Ltd.
  • Kyongbo Pharm

(Note: The list of the major players will be updated with the latest market scenario and trends)

By API Type

  • Penicillin Antibiotics
    • Ampicillin
    • Amoxicillin
    • Dicloxacillin
    • Penicillin G Sodium
    • Benzathine
    • Procaine
  • Cephalosporins
    • Cefotaxime
    • Ceftriaxone
    • Cefuroxime
    • Cefalotin
  • Carbapenem Antibiotics
    • Meropenem
    • Imipenem
    • Ertapenem

By End-User

  • Pharmaceutical Companies
  • Contract Manufacturing Organizations (CMOs)
  • Contract Development and Manufacturing Organizations (CDMOs)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Antibiotic Active Pharmaceutical Ingredient Market By API Type, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Antibiotic Active Pharmaceutical Ingredient Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antibiotic Active Pharmaceutical Ingredient Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Antibiotic Active Pharmaceutical Ingredient Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Antibiotic Active Pharmaceutical Ingredient Market, By API Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Penicillin Antibiotics
         1.1. Ampicillin
         1.2. Amoxicillin
         1.3. Dicloxacillin
         1.4. Penicillin G Sodium
         1.5. Benzathine
         1.6. Procaine
        2. Cephalosporins
         2.1. Cefotaxime
         2.2. Ceftriaxone
         2.3. Cefuroxime
         2.4. Cefalotin
        3. Carbapenem Antibiotics
         3.1. Meropenem
         3.2. Imipenem
         3.3. Ertapenem

  • 8.   Antibiotic Active Pharmaceutical Ingredient Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical Companies
        2. Contract Manufacturing Organizations (CMOs)
        3. Contract Development and Manufacturing Organizations (CDMOs)

  • 9.   North America Antibiotic Active Pharmaceutical Ingredient Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Antibiotic Active Pharmaceutical Ingredient Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Antibiotic Active Pharmaceutical Ingredient Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Antibiotic Active Pharmaceutical Ingredient Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Sandoz International GmbH
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Centrient Pharmaceuticals
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. CordenPharma International
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. ACS DOBFAR SPA
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Nanjing Dorra Pharmaceutical Technology Co. Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. DAEWOONG PHARMACEUTICAL CO. LTD.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Parabolic Drugs Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Penam Laboratories Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. ASIATIC DRUGS PHARMACEUTICALS PVT. LTD.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Fresenius Kabi
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. The United Laboratories International Holdings Limited
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Aurobindo Pharma Limited
         12.1. Company Overview
         12.2. Product Portfolio
            12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Unimark Remedies Ltd.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Savior Lifetec
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Shenzhen Haibin Pharmaceutical Co., Ltd.
         15. 1. Company Overview
         15. 2. Product Portfolio
         15. 3. SWOT Analysis
         15. 4. Financial Overview
         15. 5. Strategic Overview
        16. Sterile India Pvt. Ltd.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Zhejiang Jiuzhou Pharmaceutical Co. Ltd.
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Kyongbo Pharm
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients